The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems
Open accessAbstract
Lipid-based drug delivery systems, or lipidic carriers, are being extensively employed to enhance the bioavailability of poorly-soluble drugs. They have the ability to incorporate both lipophilic and hydrophilic molecules and protecting them against degradation in vitro and in vivo. There is a number of physical attributes of lipid-based nanocarriers that determine their safety, stability, efficacy, as well as their in vitro and in vivo behaviour. These include average particle size/diameter and the polydispersity index (PDI), which is an indication of their quality with respect to the size distribution. The suitability of nanocarrier formulations for a particular route of drug administration depends on their average diameter, PDI and size stability, among other parameters. Controlling and validating these parameters are of key importance for the effective clinical applications of nanocarrier formulations. This review highlights the significance of size and PDI in the successful design, formulation and development of nanosystems for pharmaceutical, nutraceutical and other applications. Liposomes, nanoliposomes, vesicular phospholipid gels, solid lipid nanoparticles, transfersomes and tocosomes are presented as frequently-used lipidic drug carriers. The advantages and limitations of a range of available analytical techniques used to characterize lipidic nanocarrier formulations are also covered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prausnitz, M. R., & Langer, R. (2008) · Nature Biotechnology · doi:10.1038/nbt.1504 · Cited by 3,517
The effect of particle design on cellular internalization pathways
Gratton, S. E. A., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., & DeSimone, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801763105 · Cited by 2,918
Liposomal Formulations in Clinical Use: An Updated Review
Bulbake, U., Doppalapudi, S., Kommineni, N., & Khan, W. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9020012 · Cited by 2,156
Filipe, V., Hawe, A., & Jiskoot, W. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0073-2 · Cited by 1,885 · cited 2×
“For NTA analysis, samples are injected into the special cell and then illuminated by laser light (635 nm) that passes through a liquid layer on the optical surface [104,105].”
MethodLabiris, N. R., & Dolovich, M. B. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01892.x · Cited by 1,245
Putnam, C. D., Hammel, M., Hura, G. L., & Tainer, J. A. (2007) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583507004635 · Cited by 1,184
Maeda, H. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.01.002 · Cited by 1,179 · cited 2×
“This phenomena is known as the enhanced permeability and retention (EPR) effect, which eventually enables the circulating nanocarriers smaller than around 150 nm to extravasate from circulation through the tumour vasculature and increase the concentration of the chemotherapeutic agents within the tumour [36–38].”
BackgroundCellular Uptake, Intracellular Trafficking, and Cytotoxicity of Nanomaterials
Zhao, F., Zhao, Y., Liu, Y., Chang, X., Chen, C., & Zhao, Y. (2011) · Small · doi:10.1002/smll.201100001 · Cited by 1,175
Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,125
Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization
Sun, Q., Zhou, Z., Qiu, N., & Shen, Y. (2017) · Advanced Materials · doi:10.1002/adma.201606628 · Cited by 1,058
Transdermal Drug Delivery: Penetration Enhancement Techniques
Benson, H. (2005) · Current Drug Delivery · doi:10.2174/1567201052772915 · Cited by 712
The journey of a drug-carrier in the body: An anatomo-physiological perspective
Bertrand, N., & Leroux, J.-C. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.098 · Cited by 707
Particle size of liposomes influences dermal delivery of substances into skin
Verma, D. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00183-2 · Cited by 702
Particle Engineering for Pulmonary Drug Delivery
Chow, A. H. L., Tong, H. H. Y., Chattopadhyay, P., & Shekunov, B. Y. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9174-3 · Cited by 645
Kraft, J. C., Freeling, J. P., Wang, Z., & Ho, R. J. Y. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23773 · Cited by 606
Sarin, H. (2010) · Journal of Angiogenesis Research · doi:10.1186/2040-2384-2-14 · Cited by 562
Particle Size Analysis in Pharmaceutics: Principles, Methods and Applications
Shekunov, B. Y., Chattopadhyay, P., Tong, H. H. Y., & Chow, A. H. L. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9146-7 · Cited by 545
Solid lipid nanoparticles for targeted brain drug delivery.
BLASI, P., GIOVAGNOLI, S., SCHOUBBEN, A., RICCI, M., & ROSSI, C. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.011 · Cited by 506
Targeting kidney mesangium by nanoparticles of defined size
Choi, C. H. J., Zuckerman, J. E., Webster, P., & Davis, M. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103573108 · Cited by 502
Mezei, M., & Gulasekharam, V. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90268-4 · Cited by 501
Drug and gene targeting to the brain with molecular trojan horses
Pardridge, W. M. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd725 · Cited by 439
Abdelaziz, H. M., Gaber, M., Abd-Elwakil, M. M., Mabrouk, M. T., Elgohary, M. M., Kamel, N. M., Kabary, D. M., Freag, M. S., Samaha, M. W., Mortada, S. M., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.036 · Cited by 409
Liposomes: an overview of manufacturing techniques.
Mozafari, M. R. (2005) · PubMed · Cited by 399
Self-citationEncyclopedic Dictionary of Polymers
(2011) · Springer eBooks · doi:10.1007/978-1-4419-6247-8 · Cited by 373
Liposomes: A Review of Manufacturing Techniques and Targeting Strategies
Maherani, B., Arab-Tehrany, E., R. Mozafari, M., Gaiani, C., & Linder, M. (2011) · Current Nanoscience · doi:10.2174/157341311795542453 · Cited by 369
Lipid-based nano-delivery systems for skin delivery of drugs and bioactives
Hua, S. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00219 · Cited by 304
Nanoliposomes: Preparation and Analysis
Mozafari, M. R. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-360-2_2 · Cited by 291
Self-citationGreish, K., Fang, J., Inutsuka, T., Nagamitsu, A., & Maeda, H. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342130-00002 · Cited by 278
Liposomes—A selective drug delivery system for the topical route of administration: gel dosage form
Mezei, M., & Gulasekharam, V. (1982) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1982.tb04767.x · Cited by 268
Biodegradable polymeric nanocarriers for pulmonary drug delivery
Rytting, E., Nguyen, J., Wang, X., & Kissel, T. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.6.629 · Cited by 266
Verma, D. D., Verma, S., Blume, G., & Fahr, A. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(03)00021-3 · Cited by 265
Amoabediny, G., Haghiralsadat, F., Naderinezhad, S., Helder, M. N., Akhoundi Kharanaghi, E., Mohammadnejad Arough, J., & Zandieh-Doulabi, B. (2018) · International Journal of Polymeric Materials and Polymeric Biomaterials · doi:10.1080/00914037.2017.1332623 · Cited by 256
Cytochrome c Oxidase and the Regulation of Oxidative Phosphorylation
Ludwig, B., Bender, E., Arnold, S., Hüttemann, M., Lee, I., & Kadenbach, B. (2001) · ChemBioChem · doi:10.1002/1439-7633(20010601)2:6<457::aid-cbic457>3.0.co;2-f · Cited by 245
Miller, G. (2002) · Science · doi:10.1126/science.297.5584.1116 · Cited by 240
Gabizon, A. A., Barenholz, Y., & Bialer, M. (1993) · Pharmaceutical Research · doi:10.1023/a:1018907715905 · Cited by 237
Targeted therapy for brain tumours
Lesniak, M. S., & Brem, H. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1414 · Cited by 234
The influence of particle size of liposomes on the deposition of drug into skin
DUPLESSIS, J., RAMACHANDRAN, C., WEINER, N., & MULLER, D. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90178-3 · Cited by 205
Controlled pulmonary drug and gene delivery using polymeric nano-carriers
Beck-Broichsitter, M., Merkel, O. M., & Kissel, T. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.004 · Cited by 200
Chen, M., Liu, X., & Fahr, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.02.006 · Cited by 183
Negussie, A. H., Yarmolenko, P. S., Partanen, A., Ranjan, A., Jacobs, G., Woods, D., Bryant, H., Thomasson, D., Dewhirst, M. W., Wood, B. J., et al. (2011) · International Journal of Hyperthermia · doi:10.3109/02656736.2010.528140 · Cited by 169
Effects of Size and Surface Charge of Polymeric Nanoparticles on in Vitro and in Vivo Applications
Sadat, S. M. A., Jahan, S. T., & Haddadi, A. (2016) · Journal of Biomaterials and Nanobiotechnology · doi:10.4236/jbnb.2016.72011 · Cited by 165
Improved skin permeation of methotrexate via nanosized ultradeformable liposomes
Kim, J. K., Zeb, A., Qureshi, O. S., Kim, H.-S., Cha, J.-H., & Kim, H.-S. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s109565 · Cited by 164
Nanostructured delivery systems in food: latest developments and potential future directions
Livney, Y. D. (2015) · Current Opinion in Food Science · doi:10.1016/j.cofs.2015.06.010 · Cited by 160
Zong, T., Mei, L., Gao, H., Cai, W., Zhu, P., Shi, K., Chen, J., Wang, Y., Gao, F., & He, Q. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500057n · Cited by 160
The surface properties of phospholipid liposome systems and their characterisation
Jones, M. N. (1995) · Advances in Colloid and Interface Science · doi:10.1016/0001-8686(94)00223-y · Cited by 151
Gagnadoux, F., Hureaux, J., Vecellio, L., Urban, T., Pape, A. L., Valo, I., Montharu, J., Leblond, V., Boisdron‐Celle, M., Lerondel, S., et al. (2008) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2007.0656 · Cited by 150
Tefas, L. R., Sylvester, B., Tomuță, I., Sesărman, A., Licărete, E., Banciu, M., & Porfire, A. S. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s129008 · Cited by 144
Rasti, B., Jinap, S., Mozafari, M. R., & Yazid, A. M. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2012.07.016 · Cited by 143
Self-citationAre Existing Standard Methods Suitable for the Evaluation of Nanomedicines: Some Case Studies
Gioria, S., Caputo, F., Urbán, P., Maguire, C. M., Bremer‐Hoffmann, S., Prina‐Mello, A., Calzolai, L., & Méhn, D. (2018) · Nanomedicine · doi:10.2217/nnm-2017-0338 · Cited by 141
Novel nanoliposomal encapsulated omega-3 fatty acids and their applications in food
Rasti, B., Erfanian, A., & Selamat, J. (2017) · Food Chemistry · doi:10.1016/j.foodchem.2017.03.089 · Cited by 135
Zhang, Y., Zhai, M., Chen, Z., Han, X., Yu, F., Li, Z., Xie, X., Han, C., Lian, Y., Yang, Y., et al. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1344334 · Cited by 125
Use of nanoparticle concentration as a tool to understand the structural properties of colloids
Ribeiro, L. N. D. M., Couto, V. M., Fraceto, L. F., & de Paula, E. (2018) · Scientific Reports · doi:10.1038/s41598-017-18573-7 · Cited by 125
Measurements of pulmonary epithelial permeability in vivo.
Rm, E., & Mason, G. R. (1983) · PubMed · Cited by 117
OPTIMIZATION OF MIXING TEMPERATURE AND SONICATION DURATION IN LIPOSOME PREPARATION
Putri, D. C. A., Dwiastuti, R., Marchaban, M., & Nugroho, A. K. (2017) · Journal of Pharmaceutical Sciences and Community · doi:10.24071/jpsc.142728 · Cited by 116
Tumor-imaging potential of liposomes loaded with In-111-NTA: biodistribution in mice.
Proffitt, R. T., Williams, L. E., Presant, C. A., Tin, G. W., Uliana, J. A., Gamble, R. C., & Baldeschwieler, J. D. (1983) · PubMed · Cited by 115
Clinically approved liposomal nanomedicines: lessons learned from the biomolecular corona
Caracciolo, G. (2018) · Nanoscale · doi:10.1039/c7nr07450f · Cited by 106
Role of nanocarrier systems in cancer nanotherapy
Mozafari, M. R., Pardakhty, A., Azarmi, S., Jazayeri, J. A., Nokhodchi, A., & Omri, A. (2009) · Journal of Liposome Research · doi:10.3109/08982100902913204 · Cited by 101
Self-citationLiu, C., Liu, X., Wang, G., Hei, Y., Meng, S., Yang, L., Yuan, L., & Xie, Y. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s131367 · Cited by 94
Folkesson, H. G., Weström, B. R., & Karlsson, B. W. (1990) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1990.tb08933.x · Cited by 93
Rane, S. S., & Choi, P. Y. K. (2005) · Chemistry of Materials · doi:10.1021/cm048594i · Cited by 92
Khosravi‐Darani, K., Pardakhty, A., Honarpisheh, H., Rao, V. S. N. M., & Mozafari, M. R. (2007) · Micron · doi:10.1016/j.micron.2007.06.009 · Cited by 82
Self-citationAn Updated Review On:Liposomes as Drug Delivery System
Sharma, D., Ali, A. A. E., & Trivedi, L. R. (2018) · Pharmatutor · doi:10.29161/pt.v6.i2.2018.50 · Cited by 81
Reshetov, V., Zorin, V. P., Siupa, A., D’Hallewin, M., Guillemin, F. H., & Bezdetnaya, L. (2012) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2012.01176.x · Cited by 69
Models of primitive cellular life: polymerases and templates in liposomes
Monnard, P., Lupták, A., & Deamer, D. W. (2007) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2007.2066 · Cited by 65
Systematic review of liposomes’ characterization methods
Kanásová, M., & Nesměrák, K. (2017) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/s00706-017-1994-9 · Cited by 63
Dong, Y., Tchung, E., Nowell, C. J., Kağa, S., Leong, N. J., Mehta, D. C., Kaminskas, L. M., & Boyd, B. J. (2017) · Journal of Liposome Research · doi:10.1080/08982104.2017.1391285 · Cited by 62
Analytical techniques for single-liposome characterization
Chen, C., Zhu, S., Huang, T., Wang, S., & Yan, X. (2013) · Analytical Methods · doi:10.1039/c3ay40219c · Cited by 60
Chen, C., Zhu, S., Wang, S., Zhang, W., Cheng, Y., & Yan, X. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b01867 · Cited by 54
Tocosome: Novel drug delivery system containing phospholipids and tocopheryl phosphates
Mozafari, M. R., Javanmard, R., & Raji, M. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.06.037 · Cited by 51
Self-citationTrompetero, A., Gordillo, A., del Pilar, M. C., Cristina, V., & Bustos, R. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666170828133059 · Cited by 51
(Phospho)lipid-based Nanosystems for Skin Administration
Vanić, Ž., Holsæter, A. M., & Škalko‐Basnet, N. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150901095838 · Cited by 48
A Review of Scanning Probe Microscopy Investigations of Liposome-DNA Complexes
Mozafari, M. R., Reed, C. J., Rostron, C., & Hasırcı, V. (2005) · Journal of Liposome Research · doi:10.1081/lpr-200064965 · Cited by 40
Self-citationCharacterization of a Nanoparticulate Drug Delivery System Using Scanning Ion Occlusion Sensing
Yang, L., Broom, M. F., & Tucker, I. G. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0788-3 · Cited by 32
A Review of Scanning Probe Microscopy Investigations of Liposome-DNA Complexes
Mozafari, M. R., Reed, C. J., Rostron, C., & Hasırcı, V. (2005) · Journal of Liposome Research · doi:10.1081/lpr-64965 · Cited by 31
Self-citationDevelopment of Hierarchical Magnetic Nanocomposite Materials for Biomedical Applications
Clarke, S. P. (2013) · Dublin City University Open Access Institutional Repository (Dublin City University) · Cited by 29
Nanobiotechnology for Breast Cancer Treatment
Rocha, M., Chaves, N. L., & Báo, S. N. (2017) · InTech eBooks · doi:10.5772/66989 · Cited by 29
Nanotechnology approaches to pulmonary drug delivery
Gaul, R., Ramsey, J. M., Heise, A., Cryan, S., & Greene, C. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813667-6.00006-1 · Cited by 28
Mozafari, M. R., Reed, C. J., & Rostron, C. (2007) · Micron · doi:10.1016/j.micron.2007.06.007 · Cited by 24
Self-citationFunctionalised nanostructures for transdermal delivery of drug cargos
Gul, R., Ahmed, N., Shah, K. U., Khan, G. M., & Rehman, A. U. (2017) · Journal of drug targeting · doi:10.1080/1061186x.2017.1374388 · Cited by 18
Applications of Light and Electron Microscopic Techniques in Liposome Research
Özer, A. Y. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6289-6_10 · Cited by 4
Cited by
Liu, P., Chen, G., & Zhang, J. (2022) · Molecules · doi:10.3390/molecules27041372 · Cited by 1,334
Design of liposomes as drug delivery system for therapeutic applications
Guimarães, D., Cavaco-Paulo, A., & Nogueira, E. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120571 · Cited by 1,196
Advances in drug delivery systems, challenges and future directions
Ezike, T. C., Okpala, U. S., Onoja, U. L., Nwike, C. P., Ezeako, E. C., Okpara, O. J., Okoroafor, C. C., Eze, S. C., Kalu, O. L., Odoh, E. C., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17488 · Cited by 1,040
Lombardo, D., & Kiselev, M. A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030543 · Cited by 718
Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
Scioli Montoto, S., Muraca, G., & Ruiz, M. E. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.587997 · Cited by 652
Metadata
- Authors
- Danaei, M., Dehghankhold, M., Ataei, S., Hasanzadeh Davarani, F., Javanmard, R., Dokhani, A., Khorasani, S., & Mozafari, M. R.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2018-05-18
- Volume
- 10
- Issue
- 2
- Pages
- 57
- ISSN
- 1999-4923 (ISSN-L)
- OpenAlex
- W2804846127
- Cited by
- 4,832
- References
- 80
- FWCI
- 76.78
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.